| Financial Year |
March 31 2023 |
| Monetary Funds |
403,737,896.95 |
| Held-for-trading Financial Assets |
430,562,214.61 |
| Notes Receivable |
-- |
| Accounts Receivable |
125,758,587.34 |
| Advances to Suppliers |
49,616,974.60 |
| Other Receivables |
2,191,958.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
194,091,534.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,198,310.69 |
| Total Current Assets |
1,242,157,477.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
527,035,075.94 |
| Under-construction Projects |
170,400,112.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
233,573,038.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
183,731.47 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
153,644,074.65 |
| Sub-Total of Non-Current Assets |
1,090,503,784.00 |
| Total Assets |
2,332,661,261.74 |
| Short-Term Loans |
10,088,168.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
96,563,986.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,060,921.00 |
| Taxes Payable |
4,247,452.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
87,125,014.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,592,806.45 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
582,653,895.81 |
| Long-term Loans |
253,252,458.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
285,358,116.58 |
| Total Liabilities |
868,012,012.39 |
| Paid-In Capital(Or Share Stock) |
414,080,000.00 |
| Capital Surplus |
3,054,383,527.47 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,003,806,304.18 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,464,649,249.35 |
| Owner's Equity（Stockholder's Equity） |
1,464,649,249.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,332,661,261.74 |
